MAPT and Alzheimer disease: By contrast, we have observed an inverse correlation between S100A9 and phosphorylated-tau immunostaining, i.e., neurons intensively stained for S100A9 showed no staining with phosphorylated-tau antibodies (supplemental file 4), indicating that S100A9 is not linked to AD tau-pathology.